AzTrials
AzTrials

Total Knee ArthroplastyMULTIPREPNCT06565377

Multimodal Biopsychosocial Teleprehabilitation for Total Knee Arthroplasty

A study testing Multimodal biopsychosocial teleprehabilitation and Best-evidence prehabilitation advice in people with Total Knee Arthroplasty, run by Universitair Ziekenhuis Brussel at 2 sites in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Knee replacement surgeries are one of the most frequently performed elective surgeries, with approximately 29,000 such procedures carried out annually in Belgium. Although these surgeries have been increasingly refined over the years, leading to better surgical outcomes, there is still room for improvement in terms of… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Total Knee Arthroplasty
What is being tested?
Multimodal biopsychosocial teleprehabilitation and Best-evidence prehabilitation advice
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesBelgium
Study dates
31 Jul 2024to 31 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • People scheduled for elective primary TKA at one of the participating hospitals;
  • Being over 18 years old;
  • Dutch speaking/reading

Who cannot join

  • Doing activities that make them feel out of breath for 300 minutes or more per week on average;
  • Orthopedic, neurological, cardiovascular or any other condition/comorbidity that leads to an overall contraindication for moderate physical activity;
  • Cognitive impairment (≥11 on 6-item Cognitive Impairment Test and/or unable to understand the study instructions);
  • Presence of uncontrolled inflammatory arthritides (e.g., rheumatoid arthritis, gout);
  • Uncontrolled psychiatric disorders;
  • Active cancer and/or active cancer treatment ((hormonal) maintenance therapy is allowed);
  • People undergoing emergency (non-elective) TKA.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Eva Huysmans, PhD contact

+32 2 477 44 20

eva.huysmans@vub.be

Belgium2 sites, 2 recruiting
  • Universitair Ziekenhuis Brussel

    Brussels, Brussels Capital, 1090

    Eva Huysmans, PhD, +32 2 477 44 20, eva.huysmans@vub.be

    Johan Vanlauwe, PhD

    Recruiting
  • Ziekenhuis Geel

    Geel, Antwerpen, 2440

    Eva Huysmans, PhD, +32 2 477 44 20, eva.huysmans@vub.be

    Hans Feyen, MD

    Recruiting

Other trials in Belgium

About this study

Official title: The Added Value of Multimodal Biopsychosocial Teleprehabilitation in People Undergoing Total Knee Arthroplasty: a Pilot/Feasibility Trial

Knee replacement surgeries are one of the most frequently performed elective surgeries, with approximately 29,000 such procedures carried out annually in Belgium. Although these surgeries have been increasingly refined over the years, leading to better surgical outcomes, there is still room for improvement in terms of pre-surgical biopsychosocial patient preparation. Such preparation aims to optimally inform patients before their surgery and to start preparing them for rehabilitation and resumption of activities after surgery. Therefore, we aim to assess the added value and feasibility of prehabilitation within the knee replacement care pathway.

The primary objective is to investigate the feasibility, acceptability and safety of multimodal biopsychosocial teleprehabilitation (BPS-teleprehab) for people undergoing total knee arthroplasty (TKA).

Read more

The secondary objective is to explore the effect of BPS-teleprehab versus best-evidence preoperative advice for people undergoing TKA on activity outcomes, functioning, pain, symptoms of central sensitization, quality of life, cognitive-emotional factors, joint awareness, satisfaction with the surgery, healthcare and medication use and productivity loss.

The tertiary objective is to explore baseline associations between the collected outcome measures, demographics and medical data in people scheduled for TKA.

Furthermore, this pilot trial will inform potential protocol modifications in prepara- tion of an eventual fully powered randomized controlled trial to investigate the ef- fectiveness of BPS-teleprehab in people undergoing TKA.

Being tested
Multimodal biopsychosocial teleprehabilitation, Best-evidence prehabilitation advice
Keywords
total knee arthroplasty, knee replacement, prehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multimodal biopsychosocial teleprehabilitationBehavioural

    Also called prehabilitation

    Multimodal biopsychosocial teleprehabilitation containing (pain science and lifestyle) education, stress management and physical activity promotion, guided by shared decision making, motivational interviewing and solution focused therapy principles.

    Format: 4 preoperative and 1 postoperative one-on-one (tele-)conferencing sessions with a physical therapist, supplemented by an informational booklet.

  • Best-evidence prehabilitation adviceOther

    Best-evidence prehabilitation advice in accordance with the NICE guideline on Joint Replacement (Primary): hip, knee and shoulder (2020), by means of an informational booklet.

Study groups in NCT06565377
Study groupRoleWhat they receive
Multimodal biopsychosocial teleprehabilitation (BPS-teleprehab)Experimentalsee intervention description
Receives: Behavioral: Multimodal biopsychosocial teleprehabilitation
Best-evidence prehabilitation advice (control)Active comparatorsee intervention description
Receives: Other: Best-evidence prehabilitation advice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participation rate

    This will be calculated as the ratio of the number of patients participating in the study to the number of patients eligible for study participation.

    Measured: assessed throughout the duration of the participant recruitment for the trial

  2. Patient satisfaction with the intervention (feeling of contentment with the intervention)

    This will be assessed by qualitative in-depth interviews with the study participants.

    Measured: at 6 weeks post-surgery

  3. Incidence of treatment-emergent adverse events (safety and tolerability)

    After each intervention session, patients of the experimental group will be asked whether they experienced any side effects or unexpected events associated with the intervention. Furthermore, participants are encouraged to report any side effects/unexpected events to the study team at any time throughout the study.

    Measured: At the end of each intervention session + throughout the duration of the study

  4. Compliance with the one-on-one BPS-teleprehab sessions

    The compliance rate for the teleprehabilitation sessions will be calculated as the ratio of the number of followed treatment sessions versus the number of planned treatment sessions.

    Measured: Within one week after intervention completion

  5. Compliance with home exercises

    Patients will be asked to log their home exercise sessions in an intervention log book. The compliance with these home exercise sessions is calculated as the ratio between the number of sessions performed and the number of sessions prescribed.

    Measured: Within one week after intervention completion

  6. Feasibility of BPS-teleprehab in the clinical setting

    The feasibility of BPS-teleprehab in the clinical setting will be investigated by qualitative focus group discussions with healthcare providers involved in the care trajectory of people undergoing total knee arthroplasty.

    Measured: through study completion

Secondary outcomes (14)
  1. Physical activity (objective measure)

    Actigraphy (Fitbit)

    Measured: Baseline, post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery. Actigraphy data will be registered for 1 week prior to the assessment moment for the remaining outcomes.

  2. Physical activity (patient-reported outcome)

    International Physical Activity Questionnaire

    Measured: Baseline, post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery. Actigraphy data will be registered for 1 week prior to the assessment moment for the remaining outcomes.

  3. Knee-specific pain and functioning

    Knee Injury and Osteoarthritis Outcome Score (KOOS), scale from 0-100, higher scores indicate better outcome

    Measured: Baseline, post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  4. Health-related quality of life

    EQ-5D-5L (Euroqol); scale from 0-100; higher scores indicate better quality of life

    Measured: Baseline, 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  5. Symptoms of central sensitization

    Central Sensitization Inventory; scale from 0-100; higher scores indicate more symptoms of central sensitization

    Measured: Baseline, 6 months, 12 months post-surgery.

  6. Pain catastrophizing

    Pain Catastrophizing Scale; scale from 0-52; higher scores indicate higher levels of pain catastrophizing

    Measured: Baseline, post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  7. Fear of movement and/or (re)injury

    Tampa Scale for Kinesiophobia; scores from 17-68; higher scores indicate higher levels of fear of movement

    Measured: Baseline, post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  8. Perceived Self-efficacy to exercise

    Patient-reported questionnaire based on Neupert et al. (2009); scores from 9-36; higher scores indicate greater exercise-related self-efficacy

    Measured: Baseline, post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  9. Joint awareness of the replaced joint

    Forgotten Joint Score; sores from 0 to 100; high values translating to the patient successfully "forgetting" about their joint during activities of daily living

    Measured: Post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  10. Satisfaction with surgery

    4-item satisfaction questionnaire; scores from 0-20; higher scores indicating higher levels of contentment with the surgery

    Measured: Post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  11. Total knee arthroplasty expectations

    Knee Replacement Expectations Survey; scores from 0-100; higher scores indicate higher expectations

    Measured: Baseline, post-intervention (day 4-7 post-surgery), 6 weeks post-surgery.

  12. Overall change following knee replacement surgery

    Global Rating of Change; scores from -3 to +3; more positive scores indicate a more positive change

    Measured: Post-intervention (day 4-7 post-surgery), 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  13. Healthcare and medication use

    (Modified) Medical Consumption Questionnaire

    Measured: Baseline, 6 weeks post-surgery, 6 months post-surgery (primary endpoint), 12 months post-surgery.

  14. Productivity loss/return to work

    Productivity Cost Questionnaire

    Measured: 6 months and 12 months post-surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2024
  2. Study start31 Jul 2024
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06565377
Sponsor's protocol ID
12AV224N
Acronym
MULTIPREP
Status last verified
Jun 2026
First submitted
5 Aug 2024
Last updated
15 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Open access data sharing is not possible due to the high degree of confidentiality of the pseudonymized medical and personal data. Data sharing (of pseudonymized data) is only permitted if all involved parties agree and if a data sharing agreement is signed. The research data need to be archived under restricted access due to the level of confidentiality of coded medical data. Requests for data sharing will be considered by the steering board. The informed consent allows for pseudonimyzed data sharing under these restricted conditions.

Questions about this trial

What is this clinical trial studying?

A study testing Multimodal biopsychosocial teleprehabilitation and Best-evidence prehabilitation advice in people with Total Knee Arthroplasty, run by Universitair Ziekenhuis Brussel at 2 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eva Huysmans, PhD (+32 2 477 44 20, eva.huysmans@vub.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participation rate (time frame: assessed throughout the duration of the participant recruitment for the trial). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in